About
GeneGrafts Ltd is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of the brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias. Thetechnology platform is based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of the target organ are modulated in a predetermined way.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is GeneGrafts' primary focus in biotechnology?
- GeneGrafts Ltd is a biotechnology company focused on developing proprietary cell therapy technology for modulating excitable tissues, such as the brain or heart.
- What diseases is GeneGrafts' technology designed to treat?
- GeneGrafts' technology is intended for the treatment of various diseases, including Parkinson's disease, other neurological disorders, and cardiac arrhythmias.
- What is the core mechanism of GeneGrafts' technology platform?
- The technology platform is based on transplanting cell grafts, isolated from the patient's own body, which define ion channels. These grafted cells integrate with the target organ to modulate its electrical properties.
- When was GeneGrafts founded?
- GeneGrafts was founded in November 2003.
- What is the current operational status of GeneGrafts?
- GeneGrafts is currently inactive, having ceased operations in November 2018.
- Where is GeneGrafts headquartered?
- GeneGrafts is headquartered in Haifa, Israel.
- What was the total amount of funding raised by GeneGrafts?
- GeneGrafts raised a total of $800,000 in funding. For a full financing history, please refer to startupim.
- What is GeneGrafts' primary sector classification?
- GeneGrafts' primary sector classification is Health Tech & Life Sciences.
- Does GeneGrafts hold any patents?
- Yes, GeneGrafts holds 1 patent.